This acquisition will strengthen the combined organization in the areas of medical robotics and surgical navigation, AI/machine learning, imaging, respiratory devices, IVDs and wearables to drive results for medical device innovators and emerging original equipment manufacturers (OEMs). Learn more: https://lnkd.in/gPzPGKZX #MedTech #MedicalDevice
Ironstone Product Development | Now Avania
Medical Equipment Manufacturing
Toronto, Ontario 678 followers
Ironstone Product Development is now Avania. Please visit Avania on LinkedIn.
About us
Ironstone Product Development (IPD) assists its clients with all aspects of medical and health product development and commercialization. Our team members have successfully commercialized dozens of innovative medical and healthcare products. These products have changed the practice of healthcare and have generated transformative revenue for the companies involved. We work with entrepreneurs and established companies to help define the right product and find the most efficient way to get it in the hands of the clinicians and patients that need it. Our background includes extensive work in engineering and clinical affairs, as well as regulatory strategy. This enables us to understand the details underlying how your product works both technically and clinically while clearly communicating this to regulatory bodies.
- Website
-
http://www.ironstonepd.com/
External link for Ironstone Product Development | Now Avania
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Toronto, Ontario
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Regulatory Services, Quality Management Systems, Clinical Trial Services, Due Diligence & Market Appraisals, Medical Devices, and Product Development
Locations
-
Primary
Get directions
276 Carlaw Avenue, Unit 218A
Toronto, Ontario M4M 3L1, CA
Employees at Ironstone Product Development | Now Avania
-
Mary-Anne Scott
Office Manager at IPD
-
Michael Klein
Vice President, Research and Development at Qunuba Sciences
-
Sophia Farcas
Founder & CEO @ Polycy | Medical Device Consultant @ Avania
-
Nicholas Butt
Medical Device Engineering Consultant at Ironstone Product Development | Now Avania
Updates
-
Each of our organizations bring combined strengths that benefit customers around the world — to be the trusted global partner for the MedTech community. And these solutions are comprehensive and highly customizable: https://lnkd.in/gPzPGKZX #MedTech #MedicalDevice
-
-
The newly combined organization offers unmatched high-touch strategic and operational expertise that uniquely drives results for medical device innovators and emerging original equipment manufacturers (OEMs). Read how: https://lnkd.in/gPzPGKZX #MedTech #mergerandacquisition
-
Congratulations to our client Insight Medbotics on their 510(k). This is the first FDA clearance of an MRI compatible robot, ever!
We’re thrilled to announce that the IGAR is the world’s first and only FDA-cleared, MRI-compatible robot. The clearance applies to breast biopsy indications. Thanks to our successful 510(k) application, IGAR is the first and only robotic guidance and placement system cleared to work inside an MRI bore, one of the most challenging hospital environments. Why is working in an MRI so challenging? The device uses strong magnetic fields and has a confined working area for physicians. Designing a system required a unique combination of world-class experts in minimally invasive surgery and robotics. Our story begins with Professor Mehran Anvari, a surgical robotics pioneer and the scientific director and CEO of the Centre for Surgical Invention and Innovation (CSii). His team funded the preliminary human trials for IGAR, collaborating with world-leading robotics engineers from MDA—Canada’s leading space company—to create and test the device’s first prototypes. We’re grateful to our partners at CSii, MDA, and the Canadian Government's Network of Centres of Excellence (NCE) program. In the future, the IGAR technology platform may be adapted to move seamlessly across different care environments, such as from an MRI to a standard operating room or into a physician’s office. We also envision future developments that would target other organs and disease indications, along with therapeutic delivery and device placement. We’re proud to have demonstrated IGAR’s safety and efficacy for breast biopsy in 30 patients. Our team is actively working to advance the IGAR technology to market as part of our ultimate vision to build robotics systems that make it easier to provide more targeted care everywhere. #medtech #robotics #medicaldevices
-